Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
Saks Fifth Avenue Debuts Fall 2025 Campaign
-
Hemab Therapeutics Expands Leadership with Appointment of Anant Murthy, PhD, as Chief Operating Officer
-
CEA Industries ($BNC) Expands Holdings to 388,888 BNB ($330M USD), Targets 1% Supply by Year-End
-
Genius Group and Nuanu sign $14 million Share Purchase & Joint Venture Agreement, launching Genius City, Bali
-
RedCloud Drives Global Expansion With Saudi Joint Venture
-
Rezolve Ai to Announce Strong First Half 2025 Results and Accelerated Growth Momentum
-
GDEV Strengthens Strategic Partnership with Royal Ark as Zombie Miner Reaches TOP-1 Position in its Genre
-
zerohash Trust Company is Approved to Launch
-
Catheter Precision Announces Introduction of the LockeT Product Line into Italy
-
TIAN RUIXIANG Holdings Ltd. Announces Reverse Stock Split with Marketplace Effective Date on September 5, 2025
-
ZenaTech’s Zena AI Launches a Quantum Computing Initiative for US Defense and Homeland Security Drone Applications
-
Critical Metals Corp NASDAQ CRML – Surpasses 70% Completion Milestone of the Tanbreez Bankable Feasibility Study & Remains on Schedule for Completion on or Before Q4 2025
-
SharpLink Announces Total ETH Holdings Rise to 837,230 as of August 31, 2025
-
CareCloud Increases 2025 Revenue Guidance Following Medsphere Acquisition
-
zSpace and The Glimpse Group Partner to Transform Healthcare Education with Virtual Medical Assisting Skills Training
-
Friedman Industries, Incorporated Expands with the Acquisition of Century Metals and Supplies, Inc.
-
Prairie Operating Co. Provides Operations Update
-
Perfect Moment to Present at the 2025 Gateway Conference on September 4th
-
Titomic Selects Amaero as Sole Supplier of Spherical Powders
-
Annovis to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
-
vTv Therapeutics Announces $80 Million Private Placement with Leading Healthcare Institutional Investors and the T1D Fund
-
Lakeside Software Accelerates Growth and Innovation with Three Executive Appointments
-
LanzaTech, Mibelle Group, and Fraunhofer IGB Achieve Technology Breakthrough with Production of Palm Oil Substitute
-
First Set of 1-Year Clinical Results from RESOLVE Trial in Eosinophilic Esophagitis (EoE), Durable and Sustained Symptom & Tissue Responses after Dosing with EP-104GI
-
Academy Sports + Outdoors Reports Second Quarter Fiscal 2025 Results; Updates Guidance
-
4DMT Announces Leadership Expansion with Proven Late-Stage Executives to Drive 4D-150 Execution and BLA Readiness
-
Silence Therapeutics to Participate in September Investor Conferences
-
CalPrivate Bank Appoints Kathy Moe Lonowski to the CalPrivate Bank Board
-
Karbone Research Relaunches as Noreva: AI-Powered Market Intelligence for the Energy Transition
-
Hopebridge Continues to Grow Autism Therapy Services in Founding State of Indiana
-
IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director
-
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director
-
Vielight Neuro Technology Gains Traction Across Professional Sports, Powering Champions with Evidence-Backed Results
-
PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH NUPSALA LIMITED
-
Department of Defense (DoD) Awards Nearly $1 Million to Steadman Philippon Research Institute (SPRI) for Breakthrough Study on Extracellular Vesicles Therapeutic for Joint Regeneration
-
Highridge Medical Acquires Innovative Products from Accelus to Expand Capabilities in Spine Surgery
-
PDS Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
-
Mellow Mushroom powers data-driven marketing and expansion with Bikky
-
Calidi Biotherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
Oxford Lane Capital Corp. Announces Further Detail on its Previously Announced 1-for-5 Reverse Stock Split
-
Lisata Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
Camposol Holding PLC reports Preliminary Second Quarter and First Half 2025 Results.
-
Tectonic Metals Announces Virtual Drill Core Shack and Completion of Phase One Drill Program at Flat Gold Project
-
OMass Therapeutics Enters into Exclusive Collaboration and License Agreement with Genentech to Develop and Commercialize Therapies for Inflammatory Bowel Disease
-
Step Pharma announces first participant dosed in a phase 1b clinical trial of dencatistat for essential thrombocythaemia
-
Western Announces New Chief Client Officer
-
Brenmiller Advances Tempo and Wolfson TES Projects Expected to Generate Revenue from bGen Starting 2026
-
Twin Vee Subsidiary Wizz Banger, Inc Launches WizzBanger Value App - AI-Powered Valuations for Buyers, Sellers, Dealers, and Lenders
